Login to Your Account

Pharma: Clinic roundup

Wednesday, April 30, 2014
Upsher-Smith Laboratories Inc., of Maple Grove, Minn., reported phase I data for USL261 (investigational intranasal midazolam) in patients with epilepsy were presented at the 66th Annual American Academy of Neurology (AAN) meeting in Philadelphia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription